ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint742,806 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryPlan-Les-OuatesNovImmune SA
NovImmune SA Logo
Verified· 4 sources

NovImmune SA

Summary

About the company

The core activity of NovImmune SA is the development of antibodies, in particular natural bispecific antibodies (κλ-bodies), for the treatment of cancer. The company focuses on the development of therapeutics that specifically target tumor cells by targeting specific molecules such as CD47 and CD28.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
✓ Offered6
Bispecific antibodies
Native, non-genetically engineered human bispecific antibodies based on κλ bodies; development and clinical pipeline for CD47 and CD28 targeting, as well as additional bispecific programs.
Antibody development and partnerships
Access to technology, generation of bispecific leads, and joint further development of projects across various therapeutic areas, particularly in immuno-oncology.
CD47 targeting
Selective blockade of CD47 on tumors with bispecific antibodies; tumour-directed approaches to spare normal cells.
CD28 targeting
Tumour-dependent CD28 co-stimulation via bispecific antibodies; activation of T cells only in the tumour microenvironment, including in combination with PD-L1-directed approaches.
κλ body discovery
Identification of antibodies from heavy-chain libraries, co-expression of heavy and two light chains, direct testing in cell culture supernatant, and purification by standard affinity chromatography.
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
Reviews

Aggregated rating

Aggregated rating
5
of 5

Aggregated from 1 reviews across all connected sources

Sources
GGoogle51
★TrustpilotSoon
PProvenExpertSoon

Further sources are added continuously and factored into the ranQ Rating.

Press

Media

August 16, 2022Media
Light Chain Bioscience doses first patients with solid cancers
startupticker.ch

Knowledge

No knowledge articles yet

Once NovImmune SA has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

NovImmune SA in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank NovImmune SA by reviews, experience and specialisations.

Is this your company?

Claim the company profile of NovImmune SA to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Chemin du Pré-Fleuri 15
1228 Plan-Les-Ouates
Opening hours
Mon
08:30 - 17:00
Tue
08:30 - 17:00
Wed
08:30 - 17:00
Thu
08:30 - 17:00
Fri
08:30 - 17:00
Sat
Closed
Sun
Closed

At a glance

Legal form
Corporation
UID
CHE-104.261.899
Founded
1998 · 28 years
Last commercial register change
April 28, 2026
Employees
51 to 100

Similar companies

AS
APTISSEN SA
Plan-Les-Ouates
MM
MMV MEDICINES FOR MALARIA VENTURE
Cointrin
LP
Labatec Pharma SA
Meyrin
GI
Givaudan International SA
Vernier